|
Home >> Industries >> Healthcare & Life Sciences
|
Mega trends in the Healthcare and Pharmaceutical sector have triggered a mass campaign
to inject efficiencies across the business in an effort to improve financial performance
and prevent further margin deterioration while continuing to address the growing
need for affordable healthcare and medication.
- Longer R&D cycle times due to more stringent regulatory compliance
- Rising costs per drug - now at ~$1bn, including cost of failures
- Poor prescription & consumption practices
- Growing consumer frustration due to rising prices & access barriers
- Competitive intensity - "me-too" drugs within 3-6 months coupled
with patent expiries
- Weak pipelines & fewer launches despite rising R&D spends;
Blockbuster drug challenges
- Drug recalls
- Attractive demand-side fundamentals driven by higher life expectancies
and aging population
- More informed, influential and well-networked consumers
Our consultants and domain experts will work hand-in-hand with our client-partners
to identify the right strategies for both their R&D and commercial operations
to proactively leverage and benefit from these industry trends.
|
|